- Home
- HIHO vs CVKD Comparison
HIHO vs CVKD Comparison
Compare HIHO & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- CVKD
- Stock Information
- Founded
- HIHO 1990
- CVKD 2022
- Country
- HIHO Hong Kong
- CVKD United States
- Employees
- HIHO N/A
- CVKD N/A
- Industry
- HIHO Industrial Machinery/Components
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- HIHO Industrials
- CVKD Health Care
- Exchange
- HIHO Nasdaq
- CVKD Nasdaq
- Market Cap
- HIHO 8.3M
- CVKD 29.5M
- IPO Year
- HIHO 1996
- CVKD 2023
- Fundamental
- Price
- HIHO $1.63
- CVKD $12.80
- Analyst Decision
- HIHO
- CVKD Strong Buy
- Analyst Count
- HIHO 0
- CVKD 1
- Target Price
- HIHO N/A
- CVKD $32.00
- AVG Volume (30 Days)
- HIHO 11.3K
- CVKD 32.3K
- Earning Date
- HIHO 07-31-2025
- CVKD 08-06-2025
- Dividend Yield
- HIHO 7.32%
- CVKD N/A
- EPS Growth
- HIHO N/A
- CVKD N/A
- EPS
- HIHO 0.02
- CVKD N/A
- Revenue
- HIHO $7,412,000.00
- CVKD N/A
- Revenue This Year
- HIHO N/A
- CVKD N/A
- Revenue Next Year
- HIHO N/A
- CVKD N/A
- P/E Ratio
- HIHO $81.50
- CVKD N/A
- Revenue Growth
- HIHO 17.26
- CVKD N/A
- 52 Week Low
- HIHO $1.40
- CVKD $5.70
- 52 Week High
- HIHO $2.88
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- HIHO 33.77
- CVKD 49.60
- Support Level
- HIHO $1.69
- CVKD $11.00
- Resistance Level
- HIHO $1.75
- CVKD $13.71
- Average True Range (ATR)
- HIHO 0.04
- CVKD 1.14
- MACD
- HIHO -0.01
- CVKD 0.10
- Stochastic Oscillator
- HIHO 28.00
- CVKD 63.54
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.